Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma

• Erik Hedrick,

  Affiliation Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, United States of America

  ⨯
• Syng-Ook Lee,

  Affiliation Department of Food Science and Technology, Keimyung University, Daegu, Republic of Korea

  ⨯
• Gyungeun Kim,

  Affiliation Institute of Biosciences and Technology, Texas A&M Health Sciences Center, Houston, TX, United States of America

  ⨯
• Maen Abdelrahim,

  Affiliation Department of Internal Medicine, Baylor College of Medicine, Houston, TX, United States of America

  ⨯
• Un-Ho Jin,

  Affiliations Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, United States of America, Institute of Biosciences and Technology, Texas A&M Health Sciences Center, Houston, TX, United States of America

  ⨯
• Stephen Safe ,

  * E-mail: ssafe@cvm.tamu.edu (SS), aabudayyeh@mdanderson.org (AA)

  Affiliations Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, United States of America, Institute of Biosciences and Technology, Texas A&M Health Sciences Center, Houston, TX, United States of America

  ⨯
• Ala Abudayyeh

  * E-mail: ssafe@cvm.tamu.edu (SS), aabudayyeh@mdanderson.org (AA)

  Affiliation Department of General Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States of America

  ⨯